Company and summary of significant accounting policies.

No definition available.

Name:	abio_CompanyAndSummaryOfSignificantAccountingPoliciesTableLineItems
Namespace Prefix:	abio_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of patients.

+ References

No definition available.

+ Details

Name:	abio_NumberOfPatients
Namespace Prefix:	abio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of patients company plans to enroll.

+ References

No definition available.

+ Details

Name:	abio_NumberOfPatientsCompanyPlansToEnroll
Namespace Prefix:	abio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Trail endpoint term

+ References

No definition available.

+ Details

Name:	abio_TrailEndpointTerm
Namespace Prefix:	abio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The fair value of financial assets, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name:	us-gaap_FairValueDisclosureOffbalanceSheetRisksAmountAsset
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Stock Split

-URI http://asc.fasb.org/extlink&oid=6525746

+ Details

Name:	us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=abio_RegisteredDirectOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=abio_PrivateInvestmentInPublicEntityTransactionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	abio_ClinicalTrialsByPhaseAxis=abio_PhaseThreeHeartFailureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_HealthCareTrustFundAxis=abio_BestTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_HealthCareTrustFundAxis=abio_GENETICAFTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	abio_ClinicalTrialsByPhaseAxis=abio_PhaseTwoBHeartFailureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

The Company and Summary of Significant Accounting Policies (Details Textual)			9 Months Ended
	Jun. 16, 2015 USD ($)	Feb. 07, 2014 USD ($)	Sep. 30, 2015 USD ($) Patients
Company And Summary Of Significant Accounting Policies Table [Line Items]
Revenues			$ 0
Reverse stock split			0.143
Concentrations of credit risk			$ 0
Registered Direct Offering
Company And Summary Of Significant Accounting Policies Table [Line Items]
Proceeds from the issuance of security units		$ 7,900,000
Private Investment In Public Entity Transaction
Company And Summary Of Significant Accounting Policies Table [Line Items]
Proceeds from the issuance of security units	$ 34,200,000
Phase 3 heart failure (HF) trial of Gencaro \| BEST Trial
Company And Summary Of Significant Accounting Policies Table [Line Items]
Number of patients \| Patients			2,708
Phase 3 heart failure (HF) trial of Gencaro \| GENETIC-AF Trial
Company And Summary Of Significant Accounting Policies Table [Line Items]
Number of patients company plans to enroll \| Patients			420
Phase Two B Heart Failure \| GENETIC-AF Trial
Company And Summary Of Significant Accounting Policies Table [Line Items]
Number of patients company plans to enroll \| Patients			200
Trail endpoint, term			168 days